HIPEC, or Hyperthermic Intraperitoneal Chemotherapy, is a treatment technique often discussed alongside cytoreduction surgery for certain abdominal cancers. For many patients, the term sounds unfamiliar at first. Yet in specialised oncology care, it represents a focused approach designed to treat cancer cells that may remain after surgery.
The process typically involves circulating heated chemotherapy medicine within the abdominal cavity after tumor removal. The warmth allows the medication to penetrate tissues more effectively while remaining concentrated in the affected area. HIPEC is commonly considered in conditions such as peritoneal surface malignancies, advanced colorectal cancers, and some ovarian or gastric cancers. Because this treatment requires specialised expertise, it is usually performed in selected cases after careful evaluation by surgical oncology teams.
Cancer treatment decisions are rarely straightforward. Patients often have many questions about effectiveness, recovery time, and whether the treatment is suitable for their particular diagnosis. In Vile Parle, Dr. Sasmita Vadgaonkar focuses on guiding patients through these conversations with clarity and empathy. Each treatment plan is discussed in detail so patients understand the benefits, limitations, and alternatives available.
If you are exploring treatment options for abdominal cancers and want to learn more about HIPEC therapy, speaking with Dr. Sasmita Vadgaonkar in Vile Parle can help you understand whether this approach may be appropriate in your case.
